Table 4.
Baseline | 6 weeks | p-value (baseline to 6 weeks) | 3 months | p-value (baseline to 3 months) | 6 months | p-value (baseline to 6 months) | |
---|---|---|---|---|---|---|---|
External rotation (N), mean (SEM) | |||||||
Prolotherapy | 84 (7) | 96 (8) | 0.03 | 91 (10) | 0.34 | 99 (8) | 0.01 |
Corticosteroid | 83 (8) | 85 (6) | 0.58 | 93 (8) | 0.02 | 96 (9) | 0.06 |
p-value Prolotherapy versus Corticosteroid | 0.9 | 0.27 | 0.83 | 0.75 | |||
Internal rotation (N), mean (SEM) | |||||||
Prolotherapy | 89 (7) | 98 (7) | 0.11 | 98 (8) | 0.19 | 98 (7) | 0.16 |
Corticosteroid | 85 (9) | 92 (8) | 0.04 | 97 (9) | 0.06 | 94 (9) | 0.14 |
p-value Prolotherapy versus Corticosteroid | 0.76 | 0.54 | 0.92 | 0.71 | |||
Supraspinatus (N), mean (SEM) | |||||||
Prolotherapy | 59 (8) | 69 (9) | 0.09 | 77 (8) | 0.02 | 77 (8) | 0.02 |
Corticosteroid | 68 (8) | 67 (8) | 0.75 | 72 (9) | 0.46 | 71 (9) | 0.61 |
p-value Prolotherapy versus Corticosteroid | 0.41 | 0.9 | 0.72 | 0.65 | |||
Lift off (N), mean (SEM) | |||||||
Prolotherapy | 53 (5) | 65 (6) | 0.09 | 73 (6) | 0.00 | 72 (5) | 0.00 |
Corticosteroid | 50 (6) | 60 (5) | 0.02 | 63 (6) | 0.03 | 62 (7) | 0.07 |
p-value Prolotherapy versus Corticosteroid | 0.67 | 0.51 | 0.26 | 0.24 |
p-values shown in bold are statistically significant (p < 0.05).